Cannatech 2020 Media kit
CannaTech is an opportunity for journalists to get close to the leaders of the global cannabis industry. The CannaTech ecosystem encompasses leaders in science and research, public policy and government regulations, and experts from every point on the supply chain. All media inquiries should be directed to Laura Kam of Kam Global Strategies firstname.lastname@example.org, who handles all interview requests for Saul Kaye, CEO, and other CannaTech and iCAN specialists.
Dr. Sharon is a board certified neurologist practicing in the USA and Israel. He is director of headache and facial pain at Sheba Medical Center in Israel. He did his fellowship training Harvard Medical School’s Brigham and Women’s Hospital in Boston, USA and his residency training at Mount Sinai Beth Israel Hospital in New York, USA. His medical degree is from Tel Aviv University, Israel.
Mrs. Iris Bincovich is a experienced healthcare manager, with a proven track record in developing global business strategies to open and penetrate new markets. With nearly 20 years of international marketing, biz dev and sales experience, she has led and managed hundreds of successful international transactions in the OTC, cosmetics and dermatology sector.
CannaTech Blog Posts
COVID-19 Impact In the first half of 2020, CBD companies are experiencing a loss in revenue due to store closures and consumer concerns about Coronavirus
When Rylie Maedler addresses an audience there’s rarely a dry eye left in the room. By the end of her story, Rylie has gotten under
I am a pharmacist. When I studied pharmaceutical science at Sydney University 24 years ago we were not taught about the Endocannabinoid System (ECS). We